BMS Rare Heart Disease Drug 'Camzyos' Opens Prescription Path for Adolescents
The hypertrophic cardiomyopathy treatment drug 'Camzyos (generic name mavacamten)' is expected to be prescribed for adolescent patients as well.
Search results for "Ministry of Food and Drug Safety"
SK Biopharm Receives FDA Approval for Clinical Trial Plan of Alpha-emitting Radiopharmaceuticals
SK Biopharm announced on the 12th that it has received approval from the U.S. Food and Drug Administration for the clinical trial plan of its...
HK Innoen Launches Four New 'Zero Sugar' Condition Products
HK Innoen announced on the 7th that it will launch new hangover relief beverages, including three types of stick jelly...
Meals to Avoid in the New Year?...“Due to Salty Broth, It Harms Blood Vessels”
Office workers struggle every day at lunchtime. It may seem trivial, but the choice of lunch greatly affects vascular...
Is Collagen Only for Skin?… Welcome to the Era of 'Functional Collagen' That Also Cares for Hair!
As we age, the skin in the mirror does not look the same as before. When elasticity decreases and fine lines begin to...